Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1713959

registered interest
date	25/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she plans to place opioid-overdose reversal Naloxone alongside existing public access defibrillators.
tabling member constituency	Easington
tabling member printed	Grahame Morris
uin	23721
answer	answer is ministerial correction date of answer 17/05/2024 answer text <p>The Department is working to expand access to naloxone, and to increase the availability of this life saving medicine. We will shortly update legislation to enable more services and individuals to provide take-home supplies of naloxone without a prescription. This follows a public consultation in which the responses were overwhelmingly supportive of our proposals. The consultation outcome is available at:</p><p><a href="https://www.gov.uk/government/consultations/proposals-to-expand-access-to-take-home-naloxone-supplies" target="_blank">https://www.gov.uk/government/consultations/proposals-to-expand-access-to-take-home-naloxone-supplies</a></p><p>These changes mean naloxone can be given to a family member or friend of a person who is known to be using opiates, and to professionals working with people who use these drugs, to save lives in the event of an overdose.</p><p>Whilst the government has no current plans to place naloxone alongside public access defibrillators, we are committed to making naloxone as accessible as possible to those who need it. We are therefore considering the feasibility and potential benefits of a range of options, including making naloxone available in locked boxes in public places.</p><p>We have also launched a £5 million fund to tackle drug deaths across the United Kingdom, which is funding research projects that are considering other innovative ways to make naloxone more readily available. Further information is available at the following link:</p><p><a href="https://www.gov.uk/government/news/5-million-fund-to-tackle-fatal-drug-deaths-across-the-uk" target="_blank">https://www.gov.uk/government/news/5-million-fund-to-tackle-fatal-drug-deaths-across-the-uk</a></p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 17/05/2024 14:00:33 answering member 4117 label Biography information for Andrea Leadsom previous answer version 31581 answering member constituency South Northamptonshire answering member printed Andrea Leadsom answering member 4117 label Biography information for Andrea Leadsom
tabling member	3973 label Biography information for Grahame Morris

1701778

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has made a recent assessment of the potential merits of creating a national naloxone programme.
tabling member constituency	Warrington North
tabling member printed	Charlotte Nichols
uin	22406
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.</p><p>Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.</p><p>The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.</p><p>The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 22407 22408 22409 question first answered 25/04/2024 10:24:32 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4799 label Biography information for Charlotte Nichols

1701779

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the availability of naloxone across England.
tabling member constituency	Warrington North
tabling member printed	Charlotte Nichols
uin	22407
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.</p><p>Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.</p><p>The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.</p><p>The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 22406 22408 22409 question first answered 25/04/2024 10:24:32 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4799 label Biography information for Charlotte Nichols

1701780

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what her planned timetable is for publishing a response to her Department's consultation on Expanding access to naloxone.
tabling member constituency	Warrington North
tabling member printed	Charlotte Nichols
uin	22408
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.</p><p>Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.</p><p>The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.</p><p>The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 22406 22407 22409 question first answered 25/04/2024 10:24:32 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4799 label Biography information for Charlotte Nichols

1701781

registered interest
date	17/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Naloxone
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to increase awareness of naloxone.
tabling member constituency	Warrington North
tabling member printed	Charlotte Nichols
uin	22409
answer	answer is ministerial correction date of answer 25/04/2024 answer text <p>Naloxone is highly effective in reducing opioid overdose-related deaths, and the Government is working to widen access to, and increase the uptake of, this life saving drug. A prescription only medicine that is available across the United Kingdom, naloxone can be prescribed by a doctor or non-medical prescriber or provided, under a Patient Group Direction. It can also be supplied without prescription by drug services, which include specialist National Health Service and voluntary sector treatment services, as well as community pharmacies providing other substance misuse services across the UK.</p><p>Naloxone has been available for anyone to use in an emergency since 2005. There is good awareness of it, supported by earlier guidance by the Department and its agencies in 2015, 2018, 2019, and 2023. Drug treatment services and their suppliers also provide independent awareness-raising materials, targeting people who use opioids.</p><p>The Government launched a UK-wide public consultation to seek views on our proposal to amend the Human Medicines Regulations 2012 so that more professionals, services, and family members can give out take-home naloxone supplies. The consultation closed on 6 March 2024, and the responses are currently being analysed. The Government will publish its official response shortly.</p><p>The Government is working to increase naloxone carriage, and has provided additional investment in drug treatment services to support this work. In England, local authorities and their partners have been increasing naloxone supply in recent years. There are now three naloxone products available, and supply has been meeting demand. To enable the Government to respond to any future change in demand for naloxone, the Department is working with the Home Office to model scenarios where demand for naloxone may increase, and has conducted a commercial engagement exercise to better understand the naloxone market, and the market’s capacity to respond to changes in demand.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 22406 22407 22408 question first answered 25/04/2024 10:24:33 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4799 label Biography information for Charlotte Nichols